Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis

Part 2: Synopsis of B-lymphocyte targeted therapy of ANCA-associated vasculitis

J.M. Golbin, U. Specks

Division of Pulmonary and Critical Care, Mayo Clinic, Rochester, MN, USA.

Key words

Wegener’s granulomatosis, vasculitis, ANCA, B lymphocytes, rituximab.

Please address correspondence to: Ulrich Specks, MD, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

E-mail: specks.ulrich@mayo.edu

Clin Exp Rheumatol 2007; 25 (Suppl. 44): S74-S76.